Qilu Pharmaceutical Co., Ltd.

Jinan, China

Works in Cardiovascular · Dermatology · ENT · Genetic & rare · GI & liver · Hematology · Immunology · Infectious disease · Metabolic & endocrine · Musculoskeletal · Neurology · Oncology · Ophthalmology · Psychiatry · Renal & urogenital · Respiratory · Women's health

Qilu Pharmaceutical Co., Ltd. is a clinical trial sponsor based in Jinan, China. It has 103 active clinical trials with 28,619 planned participants, across 17 therapeutic areas. Since 2021 it has completed 27 trials and stopped 1 early. Its FDA record on file shows 1 inspection.

Trial track record · since 2021

103Active trials28,619 planned participants
27Completed0 with results posted
1Stopped early4% of finished trials

FDA record

1InspectionLatest 2026-05-08: Voluntary action indicated
0Warning lettersNone on file
0RecallsNone on file

Recent FDA actions

Pipeline · 103 active trials

StageTrialStatus

Questions about Qilu Pharmaceutical Co., Ltd

See the rest of this profile

A free account shows the trial list, the financials and the fundraising filings. Pro adds a watchlist: one email when FDA acts on a company you name.

Trial counts are as the sponsor reported them to ClinicalTrials.gov, for trials changed since 2021; latest update 2026-10-30.

The FDA record counts inspection classifications, warning letters and recalls FDA has published that name this company. Compare it with the industry in the free CDMO FDA inspection lookup.

Approve Suite is not affiliated with Qilu Pharmaceutical Co., Ltd..

See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.